Advertisement
Screener

JAGUAR HEALTH, INC. (JAGX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

JAGUAR HEALTH, INC. Cash Flow Breakdown

Cash flow breakdown shows where JAGUAR HEALTH, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $23.69M went out.
  • Fiscal year ended 2025-12-31: from investing, $41.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $23.67M came in.
  • Fiscal year ended 2025-12-31: change in cash, $170.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$23.69M-$41.00K$23.67M*-$170.00K
2024-12-31-$29.38M-$231.00K$31.20M*$1.53M
2023-12-31-$33.24M$34.23M*$1.00M
2022-12-31-$33.10M-$1.68M$23.18M*-$11.58M
2021-12-31-$34.97M-$6.00K-$100.00K$10.97M$3.00K$33.06M*$8.96M
2020-12-31-$15.28M-$7.00K-$406.00K$12.30M$7.60M*$4.21M
2019-12-31-$20.46M-$100.00K$21.87M*$1.31M
2018-12-31-$22.73M-$6.53K-$30.00$24.55M*$1.81M
2017-12-31-$9.82M-$1.56M-$2.42M$5.06M$8.04M*-$702.41K
2016-12-31-$14.41M$2.38M-$2.49M$7.77M*-$6.75M
2015-12-31-$14.32M-$3.00M$5.62M$12.65K$18.54M*
2014-12-31-$5.36M-$55.15K$6.07M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$5.34M*$1.86M*
2026-03-31$8.83M-$6.62M*$2.23M
2025-12-31-$5.49M*$13.00K*$9.79M*
2025-09-30-$4.69M*$6.26M*
2025-06-30-$6.20M*$2.65M*
2025-03-31-$7.31M$4.97M*-$2.31M
2024-12-31-$7.83M*-$215.00K*$2.83M*
2024-09-30-$6.34M*$0.00*$3.53M*
2024-06-30-$8.17M*$12.57M*
2024-03-31-$7.05M$12.27M*$5.20M
2023-12-31-$7.45M*$10.65M*
2023-09-30-$6.79M*$0.00*$1.41M*
2023-06-30-$9.06M*$0.00*$3.36M*
2023-03-31-$9.95M$0.00$18.81M*$8.90M
2022-12-31-$6.42M*-$361.00K*$1.64M*
2022-09-30-$8.53M*-$56.00K*$10.15M*
2022-06-30-$10.46M*$3.25M*
2022-03-31-$7.70M$8.15M*$405.00K
2021-12-31-$8.92M*$10.48M*$0.00*$0.00*-$1.00K*$3.12M*
2021-09-30-$9.43M*-$10.48M*-$50.00K*$2.00K*
2021-06-30-$9.91M*$0.00*$9.57M*
2021-03-31-$6.71M$30.87M*$24.16M
2020-12-31-$4.06M*$0.00*$2.73M*$11.95M*-$3.88M*
2020-09-30-$2.92M*$0.00*-$1.63M*$2.88M*
2020-06-30-$4.00M*$0.00*-$1.47M*$6.88M*
2020-03-31-$4.30M-$7.00K-$50.00K$2.07M*-$2.28M
2019-12-31-$3.14M*$0.00*$4.95M*
2019-09-30-$8.55M*$9.00M*
2019-06-30-$5.30M*$4.35M*
2019-03-31-$3.46M$3.47M*$4.00K
2018-12-31-$4.90M*$0.00*$0.00*$0.00*$6.74M*
2018-09-30-$2.81M*$0.00*$0.00*$0.00*$0.00*$1.12M*
2018-06-30-$5.40M*$0.00*-$1.00*$0.00*$0.00*
2018-03-31-$9.62M-$6.53K-$1.69M$2.31M$5.06M$10.99M*$7.05M
2017-12-31-$5.33M*-$11.29K*-$260.83K*$2.06M*$3.57M*
2017-09-30-$3.03M*-$2.06M*-$1.17M*$3.72M*
2017-06-30-$1.18M*-$501.65K*$3.21M*
2017-03-31-$288.72K$490.10K-$490.10K*
2016-12-31-$2.73M*$477.29K*-$477.29K*$1.86M*
2016-09-30-$3.38M*$149.78K*-$155.72K*$1.38M
2016-06-30-$3.78M*$1.66M*-$1.68M*$0.00*
2016-03-31-$4.53M$93.02K-$178.74K$4.13M
2015-12-31-$3.93M*$1.50M*$0.00*-$250.02K*$0.00*
2015-09-30-$3.36M*$0.00*$5.86M*
2015-06-30-$5.69M*$17.32M*
2015-03-31-$1.34M$1.24M*
2014-12-31-$1.74M*$0.00*$919.96K*
2014-09-30-$1.84M*$0.00*-$774.11K*
2014-06-30-$1.16M*$1.25M*
2014-03-31-$613.12K$4.68M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
HARROW, INC. (HROW)United States$1.240B-42.77
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02